Recent Quotes (30 days)

You have no recent quotes
chg | %

SQI Diagnostics Inc.  

(Public, CVE:SQD)   Watch this stock  
Find more results for SQD
0.790
0.000 (0.00%)
May 22 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.25 - 1.82
Open     -
Vol / Avg. 0.00/5,698.00
Mkt cap 31.46M
P/E     -
Div/yield     -
EPS -0.17
Shares 39.83M
Beta 1.00
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2012
Net profit margin - -52591.67%
Operating margin - -52591.67%
EBITD margin - -47183.33%
Return on average assets -82.95% -102.92%
Return on average equity -95.06% -145.78%
Employees 36 -
Carbon Disclosure Rating - -

Address

36 Meteor Drive
Toronto, ON M9W 1A4
Canada
+1-416-6749500 (Phone)
+1-416-6749300 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

SQI Diagnostics Inc. (SQI) is a Canada-based life sciences company. The Company develops and commercializes technologies and products for microarray diagnostics. The Company provides clinical, reference, academic and diagnostic development laboratories in the In Vitro Diagnostics (IVD) segment and diagnostic companies, contract research organizations (CRO), and pharmaceutical and vaccine developers, which requires diagnostic processing equipment and consumable tests in the Diagnostic Tools and Services segment. The Company�s products include SQiDworks, SQiDlite, SQiD-X, IgX PLEX Rheumatoid Arthritis, IgX PLEX Celiac, Ig_PLEX Celiac DGP Panel, Ig_PLEX Vasculitis Panel, 8 plex Cytokine RUO, Ig_PLEX Rheumatoid Arthritis, Ig_PLEX Lupus Panel, Ig_PLEX TNF, Ig_PLEX IBD and Ig_PLEX APS.

Officers and directors

Eric N. Schneider Independent Chairman of the Board
Claude Ricks President, Chief Executive Officer, Director
Andrew Morris Chief Financial Officer
Peter Lea Ph.D. Director
Paul J. Mountain Independent Director
Saied Nadjafi Independent Director
David A. Williams Independent Director
Peter D. Winkley Independent Director